Covaxin
-
WHO commences emergency use listing review process of Covaxin: Govt
India | Jul 27, 2021, 11:30 PM ISTResponding to a question on whether it has come to the notice of the government that Covaxin used in India is not recognised by many countries, Pawar said the government is aware that Covaxin at present is not part of WHO Emergency Use Listing (EUL).
-
'Very low' Covaxin stock, meagre supply of doses likely to hit inoculation: Bengal official
India | Jul 25, 2021, 06:26 AM ISTWest Bengal has vaccinated over 2.75 crore people so far and out of them, 81.9 lakh got the second dose, the health official said.
-
Covid Vaccines for children to be available by September: Dr.Randeep Guleria
News | Jul 24, 2021, 02:22 PM ISTAIIMS chief Dr Randeep Guleria on said that Bharat Biotech's Covaxin trials for children are presently underway and the results are expected to be released by September.
-
CLAT 2021 exam analysis: 'Paper was moderately difficult'; check candidates, experts' reactions
Education | Jul 23, 2021, 10:02 PM ISTThe candidates found the Quantitative and Logical reasoning section a bit difficult, while sections like English, GK and Current Affairs were appeared to be easy.
-
Bharat Biotech terminates agreement with Brazilian partners after graft allegations
India | Jul 23, 2021, 11:47 PM ISTThe termination of the MoU came after the deal with the Brazilian government for supply of 20 million doses of the vaccine landed in controversy and attracted investigation by authorities in that country.
-
AIIMS Delhi to begin Covaxin second dose trial on 2-6 age group next week
India | Jul 23, 2021, 08:34 AM ISTTrials for coronavirus vaccine for children are underway in the country ahead of an anticipated third wave of the pandemic.
-
India administers over 40 crore Covid vaccine doses
India | Jul 17, 2021, 11:46 PM IST"India's cumulative COVID vaccination coverage has surpassed 40 crore (40,44,67,526)," according to a provisional report compiled at 7 pm.
-
Govt to procure 66 crore more doses of Covishield, Covaxin at revised rates
India | Jul 17, 2021, 12:48 PM ISTThe Union government had earlier allowed states and private hospitals to procure 50 per cent of the vaccines following demands for decentralisation of the process.
-
Bharat Biotech partner Ocugen seeks approval for Covaxin in Canada
India | Jul 16, 2021, 10:51 AM ISTThe rolling submission process was recommended and accepted under the Minister of Health's Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19.
-
Dip in average daily vaccination against COVID-19 since June 21: Govt data
India | Jul 12, 2021, 01:55 PM ISTA decline in average daily vaccination against the coronavirus has been seen since June 21, when the new phase of universalisation of COVID-19 vaccination commenced, government data showed.
-
Over 1.54 crore unutilised COVID-19 vaccine doses available with states, private hospitals: Centre
India | Jul 12, 2021, 11:15 AM ISTMore than 1.54 crore balance and unutilised COVID-19 vaccine doses are still available with the states, UTs and private hospitals to be administered.
-
Only a day's stock of COVID-19 vaccines left in Delhi: Official data
India | Jul 10, 2021, 11:25 PM ISTAccording to CoWIN portal, 79,626 vaccine doses were administered on Saturday, taking the total number of doses administered in the national capital to 88,90,766, of which 20,76,571 were second doses.
-
Decision on Emergency Use Listing of Covaxin likely in August first week: WHO
India | Jul 10, 2021, 04:33 PM ISTSpeaking at a webinar organised by the Centre for Science and Environment (CSE) on Friday, Soumya Swaminathan said the WHO is reviewing Covaxin as its manufacturer Bharat Biotech is now uploading its entire data on the health body’s portal.
-
Maharashtra: Covishield vaccine out of stock at Pune vaccination centres
India | Jul 05, 2021, 09:05 AM ISTThe Pune mayor on Sunday said that the Covishield will not be available at any vaccination centre under the jurisdiction of Pune Municipal Corporation today.
-
Bharat Biotech concludes phase 3 Covaxin trial, claims 77.8% efficacy against COVID 19
India | Jul 03, 2021, 08:37 AM ISTCovaxin gives 77.8 per cent efficacy against COVID 19, and 65.2 per cent protection against the SARS-CoV-2, B.1.617.2 Delta variant
-
12 crore Covid vaccine doses to be provided to states, UTs this month
India | Jul 01, 2021, 05:54 PM ISTUnion Health Minister Harsh Vardhan made the announcement declaring that the states have already been informed in advance about Covid-19 vaccine supplies for July and that the information was shared with them 15 days prior, along with details about day-wise supply.
-
India tells EU nations: Accept Covishield, Covaxin or face mandatory quarantine
India | Jun 30, 2021, 09:31 PM ISTAs the European Union relaxes travel restrictions under its 'Green Passport' scheme, India has requested the members of the 27-nation grouping to individually consider allowing Indians who have taken Covishield and Covaxin vaccines to travel to Europe, sources said adding India will institute a reciprocal policy for recognition of the EU Digital Covid Certificate.
-
Brazil suspends Bharat Biotech's Covaxin order over graft allegations
India | Jun 30, 2021, 02:12 PM ISTAnnouncing the Brazil government's decision, its Health Ministry said in a statement that "with the recommendation of the Office of the Comptroller General of the Union, the Ministry of Health temporarily suspended the contract for the purchase of Covid-19 vaccine from Covaxin this Tuesday (29)."
-
'Covaxin pricing clearly established': Bharat Biotech clarifies on Brazil deal row
India | Jun 30, 2021, 12:28 PM ISTThe Covaxin contract to Brazil had landed in controversy after the South American country's Attorney General reportedly launched a probe into the deal.
-
Brazil to suspend Covaxin deal with Bharat Biotech over allegations of irregularities by President
World | Jun 30, 2021, 08:21 AM ISTBrazil had in February signed a deal with Bharat Biotech to procure 20 million doses of Covaxin for USD 324 million.